Tri-Source Pharma

Tri-Source Pharma is a specialty pharmaceutical holding company that focuses on the acquisition, management, and commercialization of medically critical and niche therapeutic products. The company operates through a portfolio of subsidiaries, most notably NextSource Biotechnology, which commercializes the oncology drug Gleostine (lomustine) for brain tumors and Hodgkin lymphoma, and Ivaoes Animal Health, which provides veterinary pharmaceuticals. Tri-Source Pharma's business model centers on identifying essential, often off-patent or hard-to-source medications and ensuring their continued availability through strategic supply chain management and commercial re-launch. The company maintains a broad distribution network serving both human healthcare providers and veterinary hospitals nationwide.